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Abstract
Primary care physicians occupy a 
vital position to impact many 
devastating conditions, especially 
those dependent upon early diagnosis, 
such as skin cancer. Skin cancer is the 
most common cancer in the United 
States and despite improvements in 
skin cancer therapy, patients with a 
delay in diagnosis and advanced 
disease continue to have a grave 
prognosis. Due to a variety of barriers, 
advanced stages of skin cancer are 
more prominent in rural populations. 
In order to improve early diagnosis 
four things are paramount: increased 
patient participation in prevention 
methods, establishment of screening 
guidelines, increased diagnostic 
accuracy of malignant lesions, and 
easier access to dermatologists. Recent 
expansion in smartphone mobile 
application technology offers simple 
ways for rural practitioners to address 
these problems. More than 100,000 
health related applications are 
currently available, with over 200 
covering dermatology. This review 
will evaluate the newest and most 
useful of those applications offered to 
enhance the prevention and early 
diagnosis of skin cancer, particularly 
in the rural population.
Introduction
Skin cancer is the most common 
cancer in the United States. More 
than 3.5 million new cases occur 
annually, and these numbers 
continue to rise.1 Of the three most 
common types of skin cancer, 
melanoma is the most deadly, 
accounting for more than 75% of all 
skin-cancer deaths.2 The lethality 
of melanoma is directly dependent 
upon the stage of the cancer at the 
time of diagnosis.3 If diagnosed 
early, almost all skin cancer can 
be successfully treated. However, 
those with delayed diagnosis 
and advanced disease continue 
to have a grave prognosis.4 
Many barriers must be overcome 
in order to increase early detection 
and survival rates. Low patient 
participation in prevention methods, 
a lack of appropriate screening, 
inaccurate diagnoses, and significant 
time backlogs for examinations by 
dermatologists are problems that 
must be addressed.5-9 Primary care 
physicians (PCPs) and physician 
extenders are the first line of defense 
to address these factors. The 
demand for effective and efficient 
delivery of health care by PCPs will 
become even greater in the near 
future, as a massive shortage of 
physicians of more than 91,000 is 
expected by 2020.10 All areas will 
surely be affected; however, the 
impact on preexisting underserved 
rural populations will be more 
severe. Fortunately, new innovations 
in smartphone mobile technology 
provide a means to assist PCPs 
when dermatology referral is limited. 
A smartphone is a mobile 
telephone that functions as a touch 
screen computer, digital camera, 
and GPS navigation unit. It also acts 
as a platform for running software 
programs called mobile applications, 
or “apps.” A great number of health 
care providers and future physicians 
are using mobile apps to deliver 
more efficient and effective health 
care.11-14 These apps function as 
decision support tools, clinical 
references, patient-education tools, 
and provide online consultation 
to areas where specialists are 
limited. Recent expansion in app 
technology offers assistance to 
rural physicians in the prevention, 
screening, and management of 
skin cancer. There are more than 
5,860 medical apps currently 
available, and this review will be 
evaluating the newest and most 
useful for dermatological diagnosis 
in a rural setting (Table 1).15
Primary Prevention 
Applications
Ultraviolet radiation (UVR) 
exposure is a major risk factor for 
the development of skin cancer.16-19 
Despite being an established 
carcinogen, many Americans 
fail to follow sun protection 
recommendations and a substantial 
portion of adolescents and young 
adults continue to engage in indoor 
tanning.20-21 Even more disturbing 
is the fact that only 60% of parents 
apply sunscreen and only 25% use 
shade to protect their children.22 
People from underserved groups 
are even less inclined to practice 
protective behaviors.23 Accordingly, 
the U.S. Preventive Service Task 
force (USPSTF) now recommends 
PCPs to counsel children and 
young adults on ways to minimize 
their exposure to UV radiation.24
The Environmental Protection 
Agency developed a standard 
by which the strength of UVR is 
measured, called the UV index 
(UVI). Multiple mobile applications 
for UVI are available, functioning 
as tools to enhance daily 
awareness and increase proper 
sun protection. After review of the 
apps, the following was the most 
inclusive and cost efficient.
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App: UV US – Weather Forecast, 
UV index and Alerts25 
Cost: Free
Overview: The US National 
Weather Service supplies the 
current and forecast UVI and 
weather for the user’s city, which 
is an advantage over similar apps 
that require user input of weather 
conditions and UVI to determine 
risk of skin damage. The “Time to 
Burn” function gives an estimated 
time of allowable exposure based 
upon the UVI, weather conditions, 
skin type, environment, and SPF. A 
“UV Hazard Alert” is also featured, 
which notifies the user once the 
UVI exceeds a certain threshold. 
Pros
• Provides current and 
forecast UVI and weather 
• Text alert when UVI is 
forecast to be high
• Provides accurate estimates 
of allowable sun exposure
Cons
• None
Conclusion: Essential prevention 
tool for all patients and practitioners.
Screening Applications
One problem limiting early 
diagnosis of melanoma is the lack 
of universal skin cancer screening 
protocols. Most authorities agree 
that those at high risk for melanoma 
require regular screening and 
monitoring (Table 2). Although a 
consensus and risk factors have 
been established, more than 40% of 
physicians fail to routinely perform 
full body skin examinations on 
their high-risk patients.7,26 Absence 
of formal resident education may 
be a contributing factor, as one 
study found more than 75% of 
U.S. residents had never been 
trained to perform a skin cancer 
examination, and 55% had never 
even observed an exam.27 
In addition to physician education, 
patient education and participation 
also plays a key role in early 
detection. A substantial portion of 
melanomas are diagnosed by self 
skin-examination (SSE).28-31 Many 
studies have validated that when 
performed correctly and routinely, 
SSEs reduce the mortality and 
morbidity of skin cancer in high 
risk patients.32-36 However, the 
majority of the population does not 
perform regular SSEs, and those 
performing SSEs do it incorrectly.37-39 
The new mobile apps provide a 
means to overcome these screening 
limitations by directly facilitating 
patient participation and supplying 
quality education, which ensures 
SSEs are performed regularly 
and correctly.40-42 Using total body 
photographs as objective evidence 
for baseline exams, the apps permit 
accurate monitoring of suspicious 
lesions and make physician-patient 
encounters more efficient with 
physician examination paramount 
for suspicious lesions.43,44 After 
review of apps, the following 
two were the most appropriate 
for screening applications. 
App: UMSkinCheck45 
Cost: Free
Overview: Developed by 
University of Michigan, this app 
provides easy-to-follow instructions 
to perform a thorough SSE. The 
“Full-Body Survey” involves taking 
23 photographs in 7 positions, which 
serves as a baseline for future lesion 
comparison. The “Lesion Tracker” 
photographs and documents the 
exact location of suspicious lesions. 
A monthly reminder function ensures 
follow up. The “Risk Calculator” 
determines the absolute risk of 
developing melanoma based upon 
ten previously determined risk 
factors.46 An introduction to the 
ABCDE criteria (Asymmetry, Border 
irregularity, Color variegation, 
Diameter >6mm, and Evolution) is 
also included for patient education. 
Pros 
• Step-by-step instructions 
for performing SSE 
•  “Lesion tracker” facilitates 
direct patient involvement 
• Allows quick identification 
of high risk patients 
• Password protection for security
Cons 
• Requires a second person to 
perform the full-body survey
• No way to retrieve password 
if forgotten; must uninstall 
the application, resulting 
in loss of all data 
Conclusion: Best overall 
tool for lesion tracking and 
SSE for high-risk patients. 
App: Doctor Mole47
Cost: $4.99
Overview: Suspicious lesions 
are photographed and computer 
software analyzes lesion for 
asymmetry, border, and color. 
User estimates diameter and 
then evolution by using the 
photograph comparison function. 
Pros 
• Provides objective 
interpretation of ABCDE 
criteria for skin lesions
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• Reminder function 
ensures follow-up
Cons
• Computer software has 
not been validated 
• Tendency of patients to 
self-diagnose and delay 
visit to physician
Conclusion: Potential adjunct 
for lesion tracking, however, 
recommendation is reserved 
due to lack of validity and 
potential patient misuse. 
Clinical Decision Support 
Applications 
Dermoscopy
Lacking advanced training, the 
diagnostic accuracy of skin cancer 
diagnosis by PCPs is inferior to 
that of dermatologists.48,49 This 
discrepancy leads to a higher rate of 
referral for benign lesions, increased 
costs to patients, and limits access 
to dermatologists. Additionally, an 
increased number of malignancies 
are overlooked. One solution to 
this problem is dermoscopy. 
Dermoscopy is a non-invasive 
clinical examination that utilizes a 
dermatoscope, a hand-held light 
magnifier, to visualize skin lesions in 
detail. This technique can distinguish 
benign versus malignant lesions 
based on pattern morphologies of 
magnified lesions. Multiple studies 
have documented the clinical 
usefulness of dermoscopy in aiding 
the diagnosis of melanoma. In one 
study, the diagnostic sensitivity of 
PCPs increased from 54% to 79% 
after only one day of training.50 
Another demonstrated that with 
proper training and experience, 
dermoscopy increased the 
diagnostic accuracy by more 
than 40%.51 These improvements 
have been validated by multiple 
meta-analyses and randomized 
trials.52-55 Dermoscopy has also 
proven useful for triaging skin 
lesions in areas where access to 
dermatologists is limited.50,56 
In the past, perceived time 
commitments have been one limiting 
factor to the use of dermoscopy, 
as traditional contact non-polarized 
dermatoscopes (NPD) required 
lesion immersion with fluid before 
examination. However, the advent of 
polarized dermatoscopes (PD) now 
allows more convenient and efficient 
evaluation without immersion fluid, 
and offers better visualizations of 
deeper structures within the lesion.57 
Several apps that are compatible 
with dermatoscopes allow physicians 
to capture and digitally store 
high-resolution photographs.
The reviews for dermatoscopes 
are limited, but several can be 
purchased for less than $500. 
Overall, the new DermLite DL3N58 
dermatoscope is the most versatile 
and has superb resolution. It 
functions as both a polarized and 
non-polarized dermatoscope, with 
or without immersion fluid, which 
allows the visualization of vessels 
and red areas, as well as recognition 
of regression areas by enhancing 
lighter colors and blue-white areas.57 
It also features new PigmentBoostTM 
illumination, which allows color 
temperature selection and improves 
visualization of pigmented structures. 
 
App: Dermoscopy: An Illustrated 
Self-Assessment Guide59
Cost: $94.99
Overview: Based on the textbook 
version from McGraw-Hill, this app 
is arranged in 5 chapters of high-
yield dermoscopy. The first chapter 
introduces the core principles of 
dermoscopy, then explains “The 
Two-Step Algorithm” used in 
analysis of a suspicious lesion. The 
remaining chapters are organized 
as a series of cases grouped by 
anatomical location and major 
dermoscopic features. Each case 
presents a history and multiple 
associated dermoscopy images, 
followed by a quiz on the criteria, risk 
level, diagnosis, and management 
of the lesion in question.
Pros: 
• 191 comprehensive cases, 
including 95 melanoma cases 
and most likely imitators. 
• Detailed dermoscopic 
images with clear labeling 
of dermoscopic features. 
• Organized layout allows easy 
navigation of material. 
Cons: 
• Price
Conclusion: Excellent 
introductory text to dermoscopy.
 
App: Handyscope60
Cost: $6.99
Overview: The user’s smartphone 
is connected to a compatible 
dermatoscope, creating a high-
resolution digital dermatoscope. 
Each image can be stored on 
a HIPPA-compliant “FotoFinder 
Hub” server or emailed to the 
physician’s computer via SSL-
encrypted messages. This permits 
instant documentation and allows 
for easy consultation to online or 
local dermatologists. The images 
can also be stored locally to patient 
profiles created within the app. For 
security precautions, a password 
can be enabled for the app. 
Pros
• Quality dermatoscopic images 
• Secure storage for backup 
and consultation service 
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• User-friendly instant 
documentation and consultation
Cons
• Requires a dermatoscope for 
premium quality images
• Price
Conclusion: Essential point-
of-care tool that will lead to 
greater efficiency and efficacy 
in skin cancer diagnosis. 
Mobile Teledermatology 
The average waiting time for 
a new patient dermatologist 
visit is 38 days, and the wait for 
surgery may be even longer.61,62 
Teledermatology (TD) may be a 
viable solution to provide faster 
dermatologic care, especially in 
underserved areas.63 TD entails 
photographing a suspicious lesion, 
sending these images along with 
clinically relevant information to an 
online board-certified dermatologist, 
or teledermatologist, who then 
evaluates the lesion, gives the 
diagnosis, and recommends 
a treatment plan (medication, 
biopsy, or referral to a local 
dermatologist) within 48-72 hours.64 
The clinical utility of TD depends 
on the quality of the image, time 
requirement for consultation, 
index lesion imaged, and cost. 
When image quality is poor, 
the confidence and diagnostic 
accuracy of teledermatologists 
are low.65,66 However, when 
dermoscopy is used in conjunction 
with teledermatology, hence 
teledermoscopy, the sensitivity 
and specificity for detecting skin 
cancer increase to 100% and 90%, 
respectively.67-69 Studies have 
shown that teledermoscopy is an 
effective triage tool with comparable 
diagnostic accuracy to in-person 
examinations.63,69-72 Teledermoscopy 
reduces costs, avoids unnecessary 
biopsies, and decreases the time 
to initial therapy.63,69,74 Patient 
satisfaction with teledermoscopy is 
nearly identical to in-person visits.75,76 
Although teledermoscopy yields a 
high degree of diagnostic accuracy 
for index lesions, referring physicians 
must not neglect the total body skin 
examination, as clinically significant 
lesions could go unnoticed.77 
In the past, widespread 
adoption of TD was limited by time 
requirements for consultation, 
as some web-based services 
take up to nineteen minutes for 
each teleconsultation.78 New 
mobile apps provide a means to 
compensate for these limitations 
by using a HIPPA-compliant 
server for both storage and 
teleconsultation, allowing physicians 
to simply store and forward.70,71
Mobile applications for TD exist 
for both local and international 
dermatologists. However, most 
consultations are not covered 
by insurance, so patients must 
absorb the cost. Fortunately, 
AccessDerm-279, an app created by 
American Academy of Dermatology 
(AAD), eludes this financial burden. 
App: AccessDerm-279
Cost: Free
Overview: AAD-sponsored 
teledermatology program 
that gives PCPs who work in 
participating clinics, free access 
to AAD dermatologists. 
Pros: 
• Free and instant access 
to dermatology expertise 
for underserved areas
Cons:
• Currently limited to 
only 16 states
Conclusion: Promising app 
for future dermatologic care 
in underserved areas. 
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Patient Reference 
Applications
Many mobile apps provide vast 
amounts of quality information; 
however, app content isn’t heavily 
regulated. This creates the 
potential for patient misinformation. 
Directing patients toward quality 
resources will not only eliminate 
misinformation, but will also fill 
knowledge gaps not addressed 
during regular office visits. 
 
App: Dermatology A-Z80
Cost: Free
Overview: This app is an 
excellent patient educational tool 
that covers many dermatological 
conditions. A description and image 
for each disease is provided, as 
well as the epidemiology and 
etiology, signs and symptoms, 
diagnostic workup, treatment, and 
prognosis. Also featured is the 
“Find a Dermatologist” function, 
which locates dermatologists 
in the surrounding area. 
Pros
• Eliminates misinformation 
• Simplicity, includes descriptions 
in terms usable by a layperson 
• Quick access to local 
dermatologist contact 
information 
Cons
• None
Conclusion: Reliable reference 
tool for all patients.
Conclusion
Mobile application technology 
offers a simple, inexpensive, 
and efficient solution in the early 
diagnosis and treatment of skin 
cancer. From providing the ability 
to quickly and efficiently screen 
suspicious lesions, to obtaining 
efficient referral and consultation 
with a dermatologist; these apps 
provide a convenient platform 
to be used by both health care 
professionals and the public. 
Dissemination and incorporation of 
these apps into everyday practice 
and in public awareness campaigns 
is critical to increase the early 
diagnosis rate for all skin cancers. 
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Appendix
Table 1. Smartphone mobile applications for skin cancer prevention, screening, and management. 
Application Function Suggested user Platform Cost
UV US – Weather 
Forecast, UV index and 
Alerts25
Prevention All patients iPhone Free
UMSkinCheck45 Risk assessmentScreening
High risk patients 
Health care providers
Students
iPhone Free
Doctor Mole47 Screening High-risk patients iPhoneAndroid $4.99
Dermoscopy: An 
Illustrated Self-
Assessment Guide59
Medical education Health care providersStudents iPhone $94.99
Handyscope60
Clinical decision 
support tool
Online Consultation
Health care providers
Students iPhone $6.99
AccessDerm79 Online Consultation Health care providersStudents
iPhone
Android Free
Dermatology A-Z80 Patient Reference All patients iPhoneAndroid Free
 
Table 2. Guidelines for skin cancer screening. 
Authority Recommendations
United States 
Preventive 
Service Task 
Force81
•  Insufficient evidence to determine whether a decrease in mortality occurs with routine whole body 
skin examination in low risk patients by PCPs or self-examination. However, physicians should 
remain alert for skin lesions with malignant features while performing physical examinations. 
•  Recommends that patients at high risk of melanoma, such as those with first-degree family history, 
be referred to dermatologist for screening examinations and monitoring. 
American 
Academy of 
Dermatology82
•  Recommends all individuals adopt a comprehensive sun protection program and perform regular 
skin self-examinations; advocates follow up evaluation on any unusual skin changes.
American Cancer 
Society83
•  Recommends skin examination and cancer-related checkup every three years in patients 20-40 
years old and annually for those > 40 years of age. 
American 
Medical
Association84
•  Advises skin self-examination monthly and yearly physician skin-examinations in patients at 
moderately increased risk. 
